Evidence map›Paper›PMID 32334323›Full record

ArticleBreast (Edinburgh, Scotland)2020

Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic.

Giuseppe Curigliano, Maria Joao Cardoso, Philip Poortmans, Oreste Gentilini, Gabriella Pravettoni, Ketti Mazzocco, Nehmat Houssami, Olivia Pagani, Elzbieta Senkus, Fatima Cardoso and 1 more

Open access · goldAbstract read
In one paragraph

Article in Breast (Edinburgh, Scotland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 3 pooled it
18.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 3 syntheses or guidelines pooled it, 232 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Article
  6. Article
  7. Impact of Covid-19 on Breast Cancer Screening.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 6 countries.

Giuseppe CuriglianoIstituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Maria Joao CardosoBreast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal; Nova Medical School, Lisbon, Portugal.
Philip PoortmansIridium Kankernetwerk, Department of Radiation Oncology, Wilrijk-Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium.
Oreste GentiliniBreast Surgery, San Raffaele University and Research Hospital, Milano, Italy.
Gabriella PravettoniIstituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy.
Ketti MazzoccoIstituto Europeo di Oncologia, IRCCS, Department of Early Drug Development, Italy; University of Milano, Milano, Italy.
Nehmat HoussamiFaculty of Medicine and Health, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Olivia PaganiService Interdisciplinaire de Cancérologie, Hopital Riviera-Chablais, Rennaz, Vaud, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), Switzerland.
Elzbieta SenkusMedical University of Gdansk, Gdansk, Poland.
Fatima CardosoBreast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Portugal.
editorial board of The Breast
University of Milan · ITChampalimaud Foundation · PTEuropean Institute of Oncology · ITGdańsk Medical University · PLSan Raffaele University of Rome · ITSwiss Group For Clinical Cancer Research · CHUniversidade Nova de Lisboa · PTUniversity of Antwerp · BEUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated disease (COVID-19) outbreak seriously challenges globally all health care systems and professionals. Expert projections estimate that despite social distancing and lockdown being practiced, we have yet to feel the full impact of COVID-19. In this manuscript we provide guidance to prepare for the impact of COVID-19 pandemic on breast cancer patients and advise on how to triage, prioritize and organize diagnostic procedures, surgical, radiation and medical treatments.

Indexed as

Practice Guidelines as TopicBetacoronavirusBreast NeoplasmsCoronavirus InfectionsCOVID-19Delivery of Health CareHumansOncology Service, HospitalPandemicsPneumonia, ViralRisk AssessmentSARS-CoV-2Triage

Identifiers

PMID32334323
PMCPMC7162626
OpenAlexW3017268195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.